Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical perspectives on echinocandin resistance among Candida species.

Current opinion in infectious diseases - 1 Dec 2015

Shields Ryan K, Nguyen M Hong, Clancy Cornelius J

Abstract excerpt

PURPOSE OF REVIEW: We review and offer our clinical perspectives on the emergence of echinocandin-resistant Candida. RECENT FINDINGS: Candida FKS gene mutations attenuate echinocandin activity, but overall mutation rates among clinical isolates remain low (Candida glabrata, ∼4%; other species, <1%). Rates are higher with prior echinocandin exposure, exceeding 50% among C. glabrata or Candida albicans isolates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida
Share to Candidiasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Echinocandins

Share to Fungal Proteins

Share to Microbial Sensitivity Tests

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 26524326
DOI: 10.1097/QCO.0000000000000215
PMCID: PMC4632243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical perspectives on echinocandin resistance among Candida species.PMID 26524326Read ↗

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.Semantic proximity Read ↗

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.Semantic proximity Read ↗

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.Semantic proximity Read ↗

Echinocandin resistance: an emerging clinical problem?Semantic proximity Read ↗

Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.Semantic proximity Read ↗

The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Semantic proximity Read ↗

Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China.Semantic proximity Read ↗

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?Semantic proximity Read ↗

Abdominal candidiasis is a hidden reservoir of echinocandin resistance.Semantic proximity Read ↗

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.